These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 6985716)

  • 1. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J; Parkinson S; Timmons S
    Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin (PGI2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity.
    Ehrman ML; Jaffe EA
    Prostaglandins; 1980 Dec; 20(6):1103-16. PubMed ID: 7010448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
    Beretz A; Stierle A; Anton R; Cazenave JP
    Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that changes in platelet cyclic AMP levels regulate the fibrinogen receptor on human platelets.
    Graber SE; Hawiger J
    J Biol Chem; 1982 Dec; 257(24):14606-9. PubMed ID: 6294072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect.
    Fujitani B; Wakitani K
    Jpn J Pharmacol; 1990 May; 53(1):25-33. PubMed ID: 2161965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
    Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets.
    Hamid S; Whittle BJ
    Br J Pharmacol; 1985 May; 85(1):285-90. PubMed ID: 2992652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired platelet prostacyclin receptor activity: a monozygotic twin study discordant for spinal cord injury.
    Kahn N; Sinha A; Bauman W
    Clin Physiol; 2001 Jan; 21(1):60-6. PubMed ID: 11168298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen interaction with human platelets: effect of other coagulation factors, prostaglandins and platelet inhibitors.
    Al-Mondhiry H; Ballard JO; McGarvey V
    Thromb Res; 1983 Aug; 31(3):415-26. PubMed ID: 20217998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
    Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic inhibition of platelet activation by plasmin and prostaglandin I2.
    Schafer AI; Zavoico GB; Loscalzo J; Maas AK
    Blood; 1987 May; 69(5):1504-7. PubMed ID: 3032310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of ethanol on rabbit platelet aggregation, secretion of granule contents, and cyclic AMP levels in the presence of prostacyclin.
    Rand ML; Gross PL; Jakowec DM; Packham MA; Mustard JF
    Thromb Haemost; 1989 Apr; 61(2):254-8. PubMed ID: 2546284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.
    Needleman P; Raz A; Minkes MS; Ferrendelli JA; Sprecher H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):944-8. PubMed ID: 218223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between prostacyclin analogue ZK 36374 and heparin in their effects upon platelet function.
    Yardumian DA; O'Flynn K; Linch DC; Machin SJ
    Br J Haematol; 1987 Mar; 65(3):325-30. PubMed ID: 2436647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
    J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet interaction with polymerizing fibrin.
    Niewiarowski S; Regoeczi E; Stewart GJ; Senyl AF; Mustard JF
    J Clin Invest; 1972 Mar; 51(3):685-99. PubMed ID: 4622107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of fibrinogen with human platelets pretreated with chymotrypsin or aggregated with ADP or thrombin: an immunocytochemical study.
    Suzuki H; Kinlough-Rathbone RL; Packham MA; Yamazaki H; Mustard JF
    Br J Exp Pathol; 1989 Aug; 70(4):479-88. PubMed ID: 2765399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.